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Dietary lipids may influence the abundance of circu-
lating inflammatory microbial factors. Hence, inflam-
mation in white adipose tissue (WAT) induced by
dietary lipids may be partly dependent on their
interaction with the gut microbiota. Here, we show
that mice fed lard for 11 weeks have increased Toll-
like receptor (TLR) activation and WAT inflammation
and reduced insulin sensitivity compared with mice
fed fish oil and that phenotypic differences be-
tween the dietary groups can be partly attributed to
differences in microbiota composition. Trif/ and
Myd88/ mice are protected against lard-induced
WAT inflammation and impaired insulin sensitivity.
Experiments in germ-free mice show that an interac-
tion between gutmicrobiota and saturated lipids pro-
motes WAT inflammation independent of adiposity.
Finally, we demonstrate that the chemokine CCL2
contributes to microbiota-induced WAT inflamma-
tion in lard-fed mice. These results indicate that
gut microbiota exacerbates metabolic inflammation
through TLR signaling upon challenge with a diet
rich in saturated lipids.
INTRODUCTION
Diets rich in saturateddietary lipids are associatedwith increased
white adipose tissue (WAT) inflammation and metabolic disease
(Kennedy et al., 2009), whereas diets rich in polyunsaturated
fatty acids have been shown to counteract inflammation and
promote a lean and metabolically healthy phenotype (Buckley
and Howe, 2009; Calder, 2006; Oh et al., 2010). Host diet also
has a major impact on gut microbial composition (Scott et al.,
2013), and changes in gut ecology can affect the inflammatory
and metabolic properties of the gut microbiota and thereby
host physiology (Tremaroli andBa¨ckhed, 2012). Studies showing
that germ-free (GF) mice are protected against diet-induced658 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The Authoobesity and exhibit reducedWAT inflammation and insulin resis-
tance (Ba¨ckhed et al., 2007; Caesar et al., 2012; Ding et al., 2010;
Rabot et al., 2010) have led to the suggestion that microbial
factorsmay directly contribute toWAT inflammation and adverse
metabolic consequences. Circulating microbial factors have,
indeed, been identified in healthy humans and mice (Caesar
et al., 2010). Furthermore, an increased influx ofmicrobial factors
has been linked to inflammation and impaired glucose meta-
bolism through activation of Toll-like receptor (TLR)-dependent
signaling (Cani et al., 2007; Henao-Mejia et al., 2012). Several ge-
netic mouse models have shown that deletion of components of
the TLR signaling pathway is associated with protection against
WAT inflammation and/or rescue ofmetabolically perturbed phe-
notypes (Jin and Flavell, 2013). However, although TLR ligands
may be of bacterial origin, they may also come from the diet or
the host (Yu et al., 2010), and, thus, gnotobiotic models are
required to determine how the gut microbiota contributes to
WAT inflammation upon diet change.
In the present paper, we aim to determinewhetherWAT inflam-
mation induced by dietary lipids is mediated through the gut mi-
crobiota and to identifymolecularmechanisms throughwhich the
gut microbiota induces macrophage accumulation in WAT.
RESULTS
Impact of Lard versus Fish-Oil Diet on Gut Microbiota
To assess how the dietary fat sources affects the microbiota, we
fed mice isocaloric diets that differed only in fat composition
(either lard or fish oil, which are rich in saturated and polyunsat-
urated lipids, respectively) (Table S1) for 11 weeks. First, we
showed that lard-fed mice gained more weight (Figure 1A),
consumed more food, and had increased feed efficiency (Fig-
ures S1A and S1B) compared with mice fed fish oil. Lard-fed
mice had reduced respiratory quotient (RQ) (Figure S1C), indic-
ative of increased fat utilization, both after 2 days and 5 weeks
of high-fat diet. The fat source did not change locomotory activ-
ity (Figure S1C), but mice fed fish oil utilized more energy for
locomotory activity (Figure S1D). As expected, the lard-fed
mice had higher fasting insulin and glucose levels, as well as
impaired insulin sensitivity, compared tomice fed fish oil (Figures
S1E–S1G).rs
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Figure 1. Mice Fed a Lard Diet Have Increased Adiposity and Distinct GutMicrobiota Composition Compared toMice Fed an Isocaloric Fish-
Oil Diet
Mice were fed high-fat diets for 11 weeks.
(A) Body weight gain of mice fed lard or fish oil (n = 15). Data indicate means ± SEM. ***p < 0.001.
(B) Principal coordinate analysis of gut microbiota composition based on unweighted UniFrac in mice fed lard or fish oil (n = 10–11 mice per group).
(C) Rarefaction curves for phylogenetic diversity in microbiota from mice fed lard or fish oil (10–9,410 sequences per sample). Data indicate means ± SD.
(D) Pie charts of gutmicrobial phyla composition inmice fed lard or fish oil for 11weeks (n = 9–10mice per group) (see Table S2 for the list of differentially abundant
taxa grouped at the phylum and genus level).
(E) Cladogram generated from LEfSe analysis, showing the most differentially abundant taxa enriched in microbiota from mice fed lard (red) or fish oil (blue).
(F) LDA scores of the differentially abundant taxa shown in (E). Taxa enriched in microbiota frommice fed lard (red) or fish oil (blue) are indicated with a positive or
negative LDA score, respectively (taxa with LDA score >2 and significance of a < 0.05 determined by Wilcoxon signed-rank test).
See also Table S2.We analyzed gut microbiota composition by 454 pyrose-
quencing of the 16S rRNA gene in cecal contents of these
mice and observed dramatic changes in the microbial ecology
according to the type of dietary fat (Figures 1B–1F; Table S2).
Principal coordinate analysis of the unweighted UniFrac showed
significant clustering of samples according to diet (Figure 1B),
and multivariate non-parametric ANOVA (adonis, 999 permuta-
tions) showed that fat source explained about 24% of the vari-
ability in microbiota composition (R2 = 0.24, p = 0.001). DiversityCellwithin samples was also affected by the type of fat, as shown
by a significant decrease in phylogenetic diversity in samples
frommice fed lard versus fish oil (Figure 1C; p = 0.001 non-para-
metric p value calculated using 999 Monte Carlo permutations
at the maximum sampled depth). Linear discriminant analysis
(LDA) effect size indicated that the genera Bacteroides, Turici-
bacter, and Bilophila were increased in lard-fed mice, while
Actinobacteria (Bifidobacterium and Adlercreutzia), lactic acid
bacteria (Lactobacillus and Streptococcus), VerrucomicrobiaMetabolism 22, 658–668, October 6, 2015 ª2015 The Authors 659
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Figure 2. Presence of TLR Ligands, LPS, and Bacterial DNA in Blood and Bacterial DNA in WAT of Mice Fed Lard and Fish Oil
(A–E) Activation of innate immunity receptors induced by stimulation with serum isolated from CONV-R mice fed lard or fish oil for 11 weeks (n = 3).
(F) Concentrations of LPS in serum isolated from CONV-R mice fed lard or fish oil for 11 weeks (n = 11–13 mice per group).
(G) Levels of 16S rDNA in blood from CONV-R mice fed lard or fish oil for 11 weeks (n = 15 mice per group).
(H) Levels of 16S rDNA in WAT from CONV-R mice fed lard or fish oil for 11 weeks (n = 15 mice per group).
Mean values ± SEM are plotted. *p < 0.05; **p < 0.01.(Akkermansia muciniphila), Alphaproteobacteria, and Deltapro-
teobacteria were increased in fish-oil-fed mice (Figures 1E
and 1F).
Using qPCR, we confirmed the increase in Akkermansia and
Lactobacillus in the cecal contents of mice fed fish oil compared
to lard for 11 weeks; we also observed a significant increase in
Lactobacillus, but not in Akkermansia, in fish-oil-fed mice after
3 weeks (Figures S1H and S1I).
Impact of Lard versus Fish-Oil Diet on TLR Activation in
Systemic Circulation
Despite the marked differences in the gut microbiota, short-
chain fatty acid (SCFA) levels were similar in cecal samples
from mice fed lard or fish oil for 11 weeks, with a minor increase
only observed for acetate relative to the total SCFAs (C2 C4) in
mice fed lard (Figures S2A–S2I). Because it is known that obesity
and high-fat diets rich in saturated lipids are associated with
increased intestinal absorption of microbial products (Caesar
et al., 2010; Cani et al., 2007), we measured the potential of
serum from vena cava to activate innate immunity receptors.
We found that TLR2 and TLR4—but not TLR5, TLR9, or
NOD2—were activated by serum from mice fed lard (Figures
2A–2E), suggesting that a lard diet promotes an increased influx
of microbial factors into the systemic circulation. In agreement
with these results, we found a trend toward increased levels of
the TLR4 ligand LPS (lipopolysaccharide) in mice fed lard for
11 weeks (Figure 2F); however, there was no difference in LPS
concentration between mice fed lard and fish oil for 3 weeks
(Figure S2J).
Impaired metabolism has been associated with bacterial
translocation from the intestine (Amar et al., 2011). Therefore,660 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The Authowe determined the levels of bacterial DNA in blood and epidid-
ymal WAT using qPCR. We found that the bacterial DNA load
was similar in blood samples from mice fed lard or fish oil for
11 weeks (Figure 2G). We observed a small increase in bacterial
load inWAT frommice fed fish oil compared to lard, but the levels
in both groups were very low (Figure 2H). We profiled the 16S
rRNA genes by Illumina sequencing and observed no significant
differences in diversity and composition in either blood or WAT
between mice fed lard or fish oil for 11 weeks (Figures S3A–
S3F). Thus, our data suggest that the gut microbiota impairs
glucose metabolism by stimulating inflammation through their
pro-inflammatory molecules rather than by translocation from
the intestine.
Lard Diet Promotes WAT Inflammation through TLR
Signaling
The increased activation of TLR in the systemic circulation of
lard-fed mice prompted us to investigate the potential role of
TLR signaling in the development of diet-induced WAT inflam-
mation. To test this, we fed lard or fish oil for 11 weeks to
mice lacking the TLR adaptor molecules MyD88 or TRIF. As
expected, mice fed fish oil gained less body weight and had
smaller adipocytes than mice fed lard, regardless of the geno-
type (Figures 3A–3C). Lard-fed Myd88/ mice were protected
against diet-induced obesity and had decreased adipocyte
size compared with lard-fed wild-type mice (Figures 3A–3C).
By contrast, TRIF deficiency did not affect body weight or adipo-
cyte size upon exposure to lard (Figures 3A–3C).
Fat type had a dramatic effect on WAT inflammation: the
number of crown-like structures (CLS; indicative of macrophage
abundance in adipose tissue andWAT inflammation) (Cinti et al.,rs
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Figure 3. Mice Lacking MyD88 or TRIF Are Protected against Lard-Diet-Induced WAT Inflammation
(A) Body weight gain of wild-type, Myd88/, and Trif/ mice fed lard or fish oil for 11 weeks. ns = 23 (wild-type lard), 7 (Myd88/ lard), 8 (Trif/ lard), 22
(wild-type fish oil), 6 (Myd88/ fish oil), and 9 (Trif/ fish oil).
(B) Distribution of adipocyte sizes in wild-type, Myd88/ and Trif/ mice fed lard (n = 4–6 mice per group).
(C) Distribution of adipocyte sizes in wild-type, Myd88/, and Trif/ mice fed fish oil. n = 8 for wild-type, and n = 4 for Myd88/ and Trif/.
(D) Representative Mac-2 immunostaining of WAT from wild-type, Myd88/, and Trif/ mice fed lard or fish oil. Scale bars, 100 mm.
(E) Quantification of CLS. ns = 7 (wild-type lard), 7 (Myd88/ lard), 5 (Trif/ lard), 7 (wild-type fish oil), 5 (Myd88/ fish oil), and 4 (Trif/ fish oil).
(F) Percentage of area occupied by CD45+ cells in WAT of wild-type, Myd88/, and Trif/ mice. ns = 7 (wild-type lard), 7 (Myd88/ lard), 5 (Trif/ lard), 3
(wild-type fish-oil), 4 (Myd88/ fish oil), and 4 (Trif/ fish oil).
Mean values ± SEM are plotted. **p < 0.01; ***p < 0.001.2005) and accumulation of CD45+ cells (leukocytes) in WAT
increased dramatically between 3 and 11 weeks on a lard diet,
whereas fish oil did not induce inflammation (Figures S4A and
S4B). The numbers of CLS and CD45+ leukocytes were signifi-
cantly lower in Myd88/ and Trif/ mice than in wild-type
mice after 11 weeks on a lard diet (Figures 3D–3F). We also
showed that fasting insulin levels were lower and that insulin
sensitivity was improved in lard-fed Myd88/ and Trif/ mice
compared to lard-fed wild-type mice (Figures S4C–S4F).
These data suggest that dietary saturated fatty acids might
mediate WAT inflammation and impaired metabolic phenotypes
through TRIF andMyD88 and that the TRIF-mediated effects are
independent of the degree of adiposity.
Interaction between Dietary Lipids and the Gut
Microbiota Affects WAT Inflammation
Our observation that knockout models for TLR signaling are pro-
tected against lard-inducedWAT inflammation is consistent with
previous reports showing that mice lacking TLR4 have reduced
WAT inflammation (Kim and Sears, 2010) and implicates micro-
bial components as mediators of the inflammatory phenotype.
To investigate the role of the microbiota in diet-induced WAT
inflammation, we fed CONV-R and GF mice lard or fish oil forCell11 weeks. Diet had the largest impact on weight gain and lard-
fed GF mice gained significantly more weight than fish-oil–fed
GF mice (Figure 4A). However, GF mice gained less body weight
than their CONV-R counterparts when fed either lard or fish oil
(Figure 4A). Increased adiposity, per se, may promote WAT
inflammation (Weisberg et al., 2003). Thus, to study the influence
of gut microbiota on WAT inflammation independent of differ-
ences in adiposity, in subsequent analyses, we used GF and
CONV-R mice with matching body weights and equal adipocyte
size distribution at the end of the feeding period for each diet
(Figures 4B and 4C).
To investigate how dietary lipids and gut microbiota affect
WAT inflammation, we performed immunohistochemistry to
analyze WAT from CONV-R and GF mice fed a lard or fish-oil
diet. As expected, we noted increased numbers of CLS and
levels of CD45+ cells in lard-fed versus fish-oil-fed mice, both
for CONV-R and GF mice (Figures 4D–4F). Importantly, we also
found that the number of CLS was higher in lard-fed CONV-R
versus GF mice and a trend (p = 0.08) toward increased levels
of CD45+ cells in CONV-R versus GF mice (Figures 4D–4F).
To further investigate how dietary lipids and gut microbiota
affect WAT inflammation metabolism, we performed a microar-
ray analysis of WAT from CONV-R and GF mice fed a lard orMetabolism 22, 658–668, October 6, 2015 ª2015 The Authors 661
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Figure 4. Gut Microbiota and Dietary Lipid Interact to Regulate WAT Inflammation Independent of Body Weight and Adipocyte Size
(A) Body weight gain of CONV-R and GF mice fed lard or fish oil for 11 weeks. ns = 34 (CONV-R lard), 19 (GF lard), 34 (CONV-R fish oil), and 18 (GF fish oil).
(B) Initial and final body weight of mice used for analysis of WAT inflammation (n = 6).
(C) Distribution of adipocyte sizes inmice used for analysis of inflammation andmetabolic perturbations. ns = 4 (CONV-R lard), 5 (GF lard), 6 (CONV-R fish oil), and
6 (GF fish oil).
(D) Representative Mac-2 immunostaining of WAT from CONV-R and GF mice fed lard or fish oil. Scale bars, 100 mm.
(E) Quantification of CLS (n = 6 mice per group).
(F) Percentage of area occupied by CD45+ cells in WAT from CONV-R and GF mice fed lard or fish oil (n = 5–6 mice per group).
(G) Principal-component analysis of global gene expression in WAT from CONV-R and GF mice fed lard or fish oil (n = 6 mice per group).
(H) Genes that are regulated by the interaction between diet and gut microbiota. WAT genes induced by the gut microbiota in mice fed lard are plotted on the y
axis, and WAT genes induced by the gut microbiota in mice fed fish oil are plotted on the x axis (n = 6 mice per group). Interaction was determined by two-way
ANOVA.
Means ± SEM are plotted. *p < 0.05; **p < 0.01; ***p < 0.001.fish-oil diet. Principal-component analysis of gene expression
data revealed that mice separated on diet in the first dimension
and on microbial status in the second dimension (Figure 4G).
We observed increased expression of genes involved in immune
processes and decreased expression of genes involved in en-
ergy generation and metabolism in lard-fed versus fish-oil-fed
CONV-Rmice (Table S3). To compare how the gutmicrobiota af-
fectsWAT gene expression inmice fed lard or fish oil, differences
in expression level between CONV-R and GF mice were plotted
for significantly regulated genes, with values for mice fed fish oil
on the x axis and values for mice fed lard on the y axis (Figure S5).
The majority of genes demonstrated a positive linear relation-
ship, indicating that many genes are regulated by the microbiota
independently of dietary lipids. Gene ontology analysis showed
that the microbiota induced expression of genes involved in,
e.g., RNA processing and mitochondrial organization in both di-
etary groups (Table S4). However, expression of genes involved
in immune processes was decreased by the gut microbiota in
fish-oil-fed mice and increased by the gut microbiota in lard-
fed mice (Table S4). We applied a two-way ANOVA to identify
genes with expression levels controlled by the interaction be-
tween dietary lipids and gut microbiota (Figure 4H). The subset662 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The Authoof these genes located in Q1 (i.e., upregulated by the gut micro-
biota in lard-fed mice and downregulated in fish-oil-fed mice)
was enriched in functional categories associated with immune
responses (Table S4). Together, these data suggest that the
gut microbiota interacts with dietary lipids to modulate WAT
inflammation.
Microbiota fromMice FedFishOil Counteracts Adiposity
and Inflammation in Mice Subsequently Fed Lard
To test whether the gut microbiota of mice fed fish oil could
attenuate inflammation and protect against diet-induced obesity
during lard feeding, we transplanted the cecal microbiota ofmice
fed fish oil or lard for 11 weeks into recipient mice pretreated with
antibiotics and then fed both groups of recipient mice a lard diet
for 3 weeks. Strikingly, mice that received fish-oil microbiota
gained less weight than mice that received lard microbiota
(Figure 5A).
Profiling of the 16S rRNA gene by Illumina sequencing of the
cecal contents from the recipient mice demonstrated that the
composition of the microbiota differed between mice that
received fish-oil or lard microbiota, even though all mice were
subsequently fed the same lard diet for 3 weeks. Principalrs
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Figure 5. Gut Microbiota Transplanted from Donor Mice Fed a Fish-Oil Diet Counteract Lard-Diet-Induced Adiposity and WAT Inflammation
Mice colonized with gut microbiota from donor mice were fed either a lard or a fish-oil diet for 11 weeks and fed a lard diet for 3 weeks.
(A) Body weight gain (n = 10 mice per group).
(B and C) Indicated here are the (B) principal coordinate analysis of gut microbiota composition based on unweighted UniFrac and (C) rarefaction curves
(10–40,610 sequences per sample) for phylogenetic diversity in microbiota (n = 10).
(D) LDA scores of the differentially abundant taxa in blood. Taxa enriched in microbiota from mice fed lard (red) or fish oil (blue) are indicated with a positive or
negative LDA score, respectively (taxa with LDA score >2 and a significance of a < 0.05 determined by Wilcoxon signed-rank test are shown).
(E) Concentrations of LPS in serum (n = 8–10 mice per group).
(F) Representative Mac-2 immunostaining of WAT. Scale bars, 100 mm.
(G) Quantification of CLS (n = 10 mice per group).
(H) Percentage of area occupied by CD45+ cells (n = 10 mice per group).
Mean values ± SEM are plotted. *p < 0.05; **p < 0.01.coordinate analysis showed significant clustering of samples ac-
cording to donor diet (Figure 5B), and multivariate non-para-
metric ANOVA showed that fat source of the donor explained
about 27% of the variability in microbiota composition (R2 =
0.27, p = 0.001) Within-sample diversity, as measured by phylo-
genetic diversity, did not differ between the two recipient groups
(Figure 5C). Finally, LDA effect size analysis indicated that taxa
belonging to Akkermansia increased in the cecum of mice that
received fish-oil microbiota, while Lactobacillus increased in
mice that received a lard microbiota (Figure 5D); these results
were confirmed by qPCR analysis (Figures S6A and S6B).
We found a trend toward decreased levels of LPS in serum
frommice transplanted with microbiota from fish-oil donors (Fig-
ure 5E). Analysis of WAT showed that the number of CLS was
slightly decreased in mice transplanted with microbiota fromCellfish-oil donors but that the CD45+ cell level was similar in both
groups (Figures 5F–5H).
CCL2 in WAT Is Induced by the Gut Microbiota and
Mediates WAT Inflammation
To investigate the mechanisms underlying the gut-microbiota-
induced WAT inflammation in lard-fed mice, we searched our
WAT microarray dataset for differentially regulated genes that
are known to be associated with macrophage recruitment.
Many previous reports have suggested that the chemokine
CCL2 is a mediator of macrophage accumulation in WAT during
obesity (Kamei et al., 2006; Kanda et al., 2006; Weisberg et al.,
2006). Indeed, we found thatCcl2 expression in WAT was higher
in lard-fed CONV-R mice than in lard-fed GF mice and that both
CONV-R and GF mice fed fish oil had low expression of Ccl2Metabolism 22, 658–668, October 6, 2015 ª2015 The Authors 663
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Figure 6. CCL2 Production in WAT Is Induced by the Gut Microbiota through Activation of MyD88, TRIF, and TLR4
(A) Expression of Ccl2 in WAT from CONV-R and GF mice fed lard or fish oil for 11 weeks (n = 6).
(B) Expression of Ccl2 in primary adipocytes stimulated for 4 hr with 2% serum from the vena cava of CONV-R or GF mice fed lard (n = 5–6 mice per group).
(C) Secretion of CCL2 from primary wild-type primary adipocytes stimulated for 4 hr with 2% serum isolated from the vena cava of CONV-R and GFmice fed lard
(n = 5–6).
(D and E) Expression of Tnfa in primary (D) adipocytes and (E) macrophages stimulated for 4 hr with 2% serum isolated from the vena cava of CONV-R and GF
mice fed lard (n = 5–6).
(F) Expression ofCcl2 in WAT fromCONV-Rwild-type,Myd88/, and Trif/mice fed lard or fish oil for 11 weeks. ns = 6 (wild-type lard), 6 (Myd88/ lard), and 4
(Trif/ lard).
(G–J) Expression ofCcl2 in (G)Myd88/, (H) Trif/, (I) Tlr4/, and (J) Tlr2/ primary adipocytes stimulated for 4 hr with 2%serum isolated from the vena cava of
CONV-R or GF mice fed lard (n = 5–6).
Mean values ± SEM are plotted. *p < 0.05; **p < 0.01; ***p < 0.001.(Figure 6A). Because theWATmicroarray dataset is from GF and
CONV-R mice with matching body weights (as shown in Figures
4B and 4C), the difference in Ccl2 expression between lard-fed
CONV-R and GF mice was independent of body weight and
adipocyte size.
To test the hypothesis that factors in the serum of lard-fed
CONV-R mice promote inflammation in WAT, primary adipo-
cytes and macrophages were exposed to serum from CONV-R
or GF mice fed lard. Gene expression and secretion of CCL2
were increased in adipocytes, but not macrophages, treated
with serum from lard-fed CONV-R mice compared to cells
treated with serum from lard-fed GF mice (Figures 6B and 6C;
Figures S7A and S7B). We showed that treatment with serum
from lard-fed CONV-R mice increased expression of Tnfa in
both adipocytes and macrophages (Figures 6D and 6E), indi-
cating that circulating microbial factors may trigger a general in-
flammatory response in both these cell types.
To study the role of innate immunity signaling in the regulation
of Ccl2, we analyzed Ccl2 expression in WAT from Myd88/
and Trif/ mice fed lard or fish oil. Ccl2 expression was lower
in WAT from lard-fed Myd88/ and Trif/ mice than that from
lard-fed wild-type mice, while Ccl2 expression in mice fed fish
oil was low regardless of genotype (Figure 6F). We also showed664 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The AuthothatCcl2 expression was not increasedwhen primaryMyd88/,
Trif/, or Tlr4/ adipocytes were exposed to serum from lard-
fed CONV-R mice compared to adipocytes treated with serum
from GF mice (compare Figures 6G–6I with 6B). In contrast,
Ccl2 expression in primary Tlr2/ adipocytes was increased
by exposure to serum from lard-fed CONV-R mice compared
to exposure to serum from GF mice (Figure 6J). These data indi-
cate that there are factors present in the blood of CONV-R mice
that induce Ccl2 expression through pathways involving TLR4,
MyD88, and TRIF but not TLR2.
To investigate whether CCL2 is involved in the development of
WAT inflammation induced by the gut microbiota and lard diet,
GF mice were conventionalized and fed a lard diet for 4 weeks
in the presence of either the CCL2 inhibitor mNOX-E36 or the
nonfunctional control substance revmNOX-E36. Mice treated
with mNOX-E36 and revmNOX-E36 did not differ in body weight
or adipocyte size (Figures 7A and 7B). Strikingly, however, con-
ventionalized mice treated with mNOX-E36 had decreased
abundance of CLS and CD45+ cells in WAT compared to mice
treated with revmNOX-E36 (Figures 7C–7E), indicating a role of
CCL2 in macrophage recruitment to WAT.
Taken together, these data suggest that CCL2 is induced by
factors in the blood of CONV-R mice fed a lard diet throughrs
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Figure 7. CCL2 Mediates WAT Inflammation
(A and B) Indicated here are the (A) body weight and (B) distribution of adipocyte size in WAT from CONV-D mice fed lard for 28 days and treated with either
revmNOX or mNOX and from GF mice fed lard for 28 days and treated with revmNOX. n = 8 (CONV-D revmNOX and CONV-D mNOX), and n = 2 (GF revmNOX).
(C) Representative Mac-2 immunostaining of WAT from CONV-D mice fed lard and treated with either revmNOX or mNOX and from GFmice fed lard and treated
with revmNOX. Scale bars, 100 mm.
(D and E) Indicated here are the (D) quantification of CLS and (E) percentage of area occupied by CD45+ cells in WAT from CONV-Dmice fed lard and treated with
either revmNOX or mNOX and from GF mice fed lard and treated with revmNOX. n = 8 (CONV-D revmNOX and CONV-D mNOX), and n = 2 (GF revmNOX).
Mean values ± SEM are plotted; *p < 0.05; **p < 0.01.mechanisms involving MyD88, TRIF, and TLR4 and that CCL2
facilitates accumulation of macrophages in WAT.
DISCUSSION
In the present study, we demonstrate that the type of dietary
lipids affects the gut microbiota and that the gut microbiota con-
tributes to the phenotypic differences betweenmice fed lard and
mice fed fish oil. Mice fed a lard diet have increased TLR activa-
tion in the systemic circulation, increased WAT inflammation,
and impaired insulin sensitivity compared to mice fed fish oil.
We found that mice lackingMyD88 or TRIF are protected against
lard-induced WAT inflammation and metabolic perturbations
and that saturated dietary lipids and the gut microbiota interact
to induce WAT inflammation. In addition, we show that CCL2
is required for microbiota-induced macrophage recruitment to
WAT in mice on a lard diet and that expression of CCL2 in adipo-
cytes is induced by factors in the blood of lard-fed CONV-Rmice
through a mechanism involving MyD88, TRIF, and TLR4.
We showed that the type of dietary fat is a major driver of com-
munity structure, affecting both the composition and diversity of
the gut microbiota. Results from 454 pyrosequencing and qPCR
showed that mice fed fish oil had increased levels of taxa from
the genera Lactobacillus, a known probiotic that has been linked
to reduced inflammation and mucosal lesion scores in several
models of inflammatory bowel diseases (Guarner et al., 2005),
and Akkermansia muciniphila, which has been shown to reduce
fat mass gain and WAT macrophage infiltration and improve
gut barrier function and glucose metabolism when administered
to mice with diet-induced obesity (Everard et al., 2013). By
contrast, mice fed lard had increased levels of taxa related to
Bilophila. Previous studies have shown that Bilophila increases
in mice and humans after consumption of diets rich in saturated
fats of animal origin (David et al., 2014; Devkota et al., 2012), and
Bilophila wadsworthia has been shown to exacerbate colitis in
genetically susceptible models (Devkota et al., 2012).
To determine whether the microbiota of fish-oil-fed mice
could confer protection against lard-diet-induced adiposityCelland inflammation, we transplanted microbiota from lard- or
fish-oil-fed mice into antibiotic-treated mice that were then fed
a lard diet for 3 weeks. Here, we used antibiotic-treated mice
rather than GF mice because it is known that GF mice have an
underdeveloped immune system (Hooper et al., 2012), which
could potentially confound this analysis. Mice that received mi-
crobiota from a lard-fed donor showed increased adiposity
and inflammation, together with a significant increase in Lacto-
bacillus, compared to mice that received microbiota from a
fish-oil-fed donor. Therefore, these data do not provide evidence
for a role of Lactobacillus in reducing inflammation. However,
we found that the enrichment of Akkermansia co-occurred with
partial protection against adiposity and inflammation in mice
transplanted with fish-oil microbiota and fed a lard diet, high-
lighting Akkermansia as a potential mediator of the improved
inflammatory and metabolic phenotype of mice fed fish oil.
This finding is in agreement with previous findings linking
Akkermansia muciniphiliawith protection to diet-induced obesity
(Everard et al., 2013; Shin et al., 2014).
Serum from mice fed lard had increased capacity to activate
TLR4, which has been linked to WAT inflammation and meta-
bolic perturbations (Caesar et al., 2012; Cani et al., 2007; Creely
et al., 2007). Furthermore, we found that mice deficient in
either of the two TLR adaptor molecules MyD88 and TRIF were
protected from lard-induced WAT inflammation and insulin
sensitivity. These findings are consistent with earlier studies
showing reduced inflammation in mouse models lacking func-
tional MyD88 (Bjo¨rkbacka et al., 2004; Everard et al., 2014;
Michelsen et al., 2004) or TRIF (Richards et al., 2013). One report
has shown that MyD88 protects against glucose homeostasis
perturbations and liver disease during a high-fat diet (Hosoi
et al., 2010). Inconsistencies in reports on the role of MyD88
may be due to environmental factors at different animal facilities.
For example, the presence of segmented filamentous bacteria,
which are enriched in Myd88/ mice (Larsson et al., 2012)
and have a major impact on host immunity (Ivanov et al.,
2009), differs between animal facilities (Kriegel et al., 2011).
Importantly, the TRIF-deficient mice in our study had the sameMetabolism 22, 658–668, October 6, 2015 ª2015 The Authors 665
body weight and adipocyte size as the wild-type mice, showing
that protection against WAT inflammation was not dependent on
reduced adiposity.
TLR signaling can be activated by both microbial and endo-
genous ligands, and some investigators have suggested that
saturated fatty acids promote inflammation and insulin re-
sistance in obesity through TLR4 (Shi et al., 2006). The gutmicro-
biota modulates host lipid metabolism (Velagapudi et al., 2010);
therefore, protection againstWAT inflammation inMyd88/ and
Trif/ mice fed lard might be due to decreased TLR signaling
induced by ligands originating from the host or from the diet.
Here, we showed that serum levels of LPS were higher in mice
fed lard compared to mice fed fish oil, indicating that microbial
factors are present in the periphery that may directly affect
WAT inflammation. However, we cannot exclude the possibility
that other factors, such as saturated lipids, also directly con-
tribute to the inflammatory response by activating TLR signaling
(Huang et al., 2012). Furthermore, to determine the specific
impact of the gut microbiota on lard-induced WAT inflammation,
we compared the effects of lard and fish oil in CONV-R versusGF
mice. As expected, GF mice were partly protected against lard-
induced WAT inflammation, although the protection against
obesity in GF mice was less than that observed in previous
studies (Ba¨ckhed et al., 2007; Caesar et al., 2012; Ding et al.,
2010; Rabot et al., 2010). This is likely due to the reduced
sucrose levels in the high-fat diets used in the present study. Su-
crose levels have previously been shown to have a major impact
on microbiota-induced obesity (Fleissner et al., 2010). We used
this fact to our benefit, as we could use weight-matched mice
to try and untangle whether the microbiota modulated WAT
inflammation by weight-dependent or -independent mecha-
nisms. Importantly, we observed an adiposity-independent link
between the gut microbiota and WAT inflammation, which may
implicate microbially derived products as mediators of inflam-
mation through TLRs. However, we also showed that GF mice
fed lard had increased WAT inflammation compared to GF
mice fed fish oil, indicating that microbiota-independent mecha-
nisms also contribute to accumulation of immune cells in WAT.
Previous studies have demonstrated that gut-microbiota-
derived factors can induce inflammation and Tnfa expression
in WAT (Caesar et al., 2012; Cani et al., 2007), and we showed
that serum from lard-fed CONV-R mice compared to GF mice
had an increased capacity to induce expression of Tnfa in both
adipocytes and macrophages. CCL2 is the only chemokine
that has been shown to mediate inflammation in a WAT-specific
knockout model (Lee and Lee, 2014), and TLR ligands have been
shown to induce secretion of CCL2 from 3T3-L1 adipocytes
(Kopp et al., 2009). Here, we found that Ccl2 expression in pri-
mary adipocytes and WAT was induced by microbial factors in
serum and required the presence of MyD88, TRIF, and TLR4.
Overexpression of Ccl2 in adipocytes has been shown to result
in WAT inflammation and insulin resistance without obesity (Ka-
mei et al., 2006; Kanda et al., 2006), and mice deficient in CCL2,
or its receptor chemokine (C-C motif) receptor 2 (CCR2), have
reduced WAT inflammation and insulin resistance during a
high-fat diet (Kanda et al., 2006; Weisberg et al., 2006). A recent
study also reported that CCL2 promotes local proliferation of
macrophages in WAT (Amano et al., 2014). By using the specific
pharmacological CCL2 inhibitor mNOX-E36 (Kulkarni et al.,666 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The Autho2007, 2009; Wlotzka et al., 2002), we demonstrated that CCL2
is essential for WAT macrophage accumulation in our model
and, therefore, constitutes a putative mediator of gut-micro-
biota-induced WAT inflammation. In addition, we found that
GF mice fed lard or fish oil had similar expression levels of
Ccl2 in WAT, suggesting that microbiota-independent WAT
inflammation is not mediated through CCL2.
Taken together, our data show that interaction between the
gut microbiota and dietary lipids induces WAT inflammation.
We also identify putative mechanisms, including the role of cell
signaling components and regulation of chemokine expression.
The study establishes the gut microbiota as an independent
factor aggravating inflammation during diet-induced obesity
and, therefore, a suitable target for therapies against associated
metabolic perturbations.EXPERIMENTAL PROCEDURES
Wild-type C57Bl/6, Myd88/, and Trif/, Tlr4/, and Tlr2/ mice were
maintained under standard specific-pathogen-free (SPF) or GF conditions as
described previously (Caesar et al., 2012). All mice were males and 11–
14 weeks of age at the start of the experiments. Mice were weight matched
at the start of the experiments, except when the aim was to compare
weight-matched mice at the end of the experiment as indicated in the text.
Mice were fed irradiated isocaloric diets (45% kcal fat) of identical composition
except for the source of fat, which was either menhaden fish oil (Research Di-
ets, D05122102) or lard (Research Diets, D10011202) (Table S1), for 11 weeks
unless otherwise indicated. The mice were fasted for 4 hr before they were
killed. Blood samples and epididymal WAT samples were harvested at the
end of the experiment. Weekly food consumption was measured cage-wise.
To study the role of CCL2 in WAT inflammation during conventionalization,
three groups of GF mice were injected subcutaneously with 20 mg/kg of the
CCL2 inhibitor mNOX-E36 (Baeck et al., 2012) or the nonfunctional control
substance revmNOX-E36 (both NOXXON Pharma) three times per week for
30 days. From day 3, the mice were fed a lard diet, and two groups of mice
(one group receiving mNOX-E36 and the other receiving revmNOX-E36)
were transferred to a conventional environment and gavaged with cecal con-
tent (isolated from a SPF 12-week-old male C57Bl/6 mouse) suspended in
200 ml PBS. The third group of mice (receiving revmNOX-E36) remained in a
GF environment.
Gut microbiota transplantation with cecal content from donor mice fed lard
or fish oil for 11 weeks was performed on male 12-week-old mice. Before the
microbial transplantation, recipient mice were treated with a 200 ml antibiotic
cocktail (ampicillin, 1 g/l; metronidazole, 1 g/l; vancomycin, 0.5 g/l; neomycin,
0.5 g/l) administrated by oral gavage once a day for 3 days. During the last 8 hr
of antibiotic treatment, mice were fed either lard or fish oil to facilitate sub-
sequent colonization. Half a frozen cecum was suspended in 5 ml of PBS con-
taining 0.2 g/l Na2S and 0.5 g/l cysteine as reducing agents in Hungate tubes.
Micewere colonized by oral gavagewith 200 ml of cecal suspension after a 4-hr
fast once a week. After the first microbiota gavage, all mice were fed a lard diet
for 3 weeks. All experiments were performed with protocols approved by the
University of Gothenburg Animal Studies Committee.
Statistical Analysis
Data are shown as means ± SEM. Statistical comparison of two groups was
performed using a Student’s t test; comparisons of three or more groups
were analyzed by one-way ANOVA with ad hoc Tukey post tests; analysis of
datasets containing multiple measurements from each mouse (weight gain,
ITT, diet consumption, and feeding efficiency) was performed with a two-
way ANOVA for repeated measurements; analysis of interaction was per-
formed with a two-way ANOVA; and analysis of covariance was performed
on linear regression. Statistical analysis was performed in GraphPad Prism 6
unless otherwise stated.
Additional experimental procedures are described in the Supplemental
Experimental Procedures.rs
ACCESSION NUMBERS
Microarray data have been uploaded to the Gene Expression Omnibus (GEO)
database with accession number GSE70922, and bacterial DNA sequencing
data have been uploaded to NCBI as PRJNA289917.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.07.026.
AUTHOR CONTRIBUTIONS
R.C.: designed, performed, and analyzed experiments. V.T., P.K.D., and
P.D.C.: performed and analyzed experiments. F.B.: conceived the project
and designed and analyzed experiments. R.C. and F.B. wrote the paper. All
authors commented and approved the paper.
ACKNOWLEDGMENTS
We thank Rosie Perkins (Wallenberg Laboratory, University of Gothenburg) for
editing the manuscript; Anna Halle´n, Gunnel O¨stergren Lunden, Carina Arvids-
son, and Alexandra Ferraro Werling for superb technical assistance; Rozita
Akrami for bioinformatics assistance; and NOXXON Pharma for providing
mNOX-E36 and revmNOX-E36. We thank Professor Willem de Vos (Wagenin-
gen University) for donating Akkermansia muciniphila, Professor Jan Bore´n
(Wallenberg Laboratory, University of Gothenburg) for donating Tlr4/ mice,
and Professor Carina Mallard (Institute of Neuroscience and Physiology,
University of Gothenburg) for donating Tlr2/mice. This work was supported
by the Swedish Research Council, the Swedish Foundation for Strategic
Research, the Swedish Diabetes Foundation, the Swedish Heart Lung Foun-
dation, the Torsten So¨derbergs and Ragnar So¨derbergs Foundations, the
Novo Nordisk Foundation, the Knut and Alice Wallenberg Foundation,
TORNADO (FP7-KBBE-222720; http://www.fp7tornado.eu/), the EU-funded
ETHERPATHS project (FP7-KBBE-222639; http://www.etherpaths.org), and
a LUA-ALF grant from Va¨stra Go¨talandsregionen. The computations were
performed on resources provided by Swedish National Infrastructure for
Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced
Computational Science (UPPMAX). F.B. is a recipient of a European Research
Council (ERC) Consolidator grant (615362 - METABASE). P.D.C. is a research
associate at FRS-FNRS (Fonds de la Recherche Scientifique) and recipient of
a FRFS-WELBIO under grant (WELBIO-CR-2012S-02R) and an ERC Starting
Grant 2013 (ERC, Starting grant 336452-ENIGMO).
Received: January 19, 2015
Revised: May 25, 2015
Accepted: July 27, 2015
Published: August 27, 2015
REFERENCES
Amano, S.U., Cohen, J.L., Vangala, P., Tencerova, M., Nicoloro, S.M., Yawe,
J.C., Shen, Y., Czech, M.P., and Aouadi, M. (2014). Local proliferation of mac-
rophages contributes to obesity-associated adipose tissue inflammation. Cell
Metab. 19, 162–171.
Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermu´dez-Humara´n,
L.G., Smirnova, N., Berge´, M., Sulpice, T., Lahtinen, S., et al. (2011). Intestinal
mucosal adherence and translocation of commensal bacteria at the early
onset of type 2 diabetes: molecular mechanisms and probiotic treatment.
EMBO Mol. Med. 3, 559–572.
Ba¨ckhed, F., Manchester, J.K., Semenkovich, C.F., and Gordon, J.I. (2007).
Mechanisms underlying the resistance to diet-induced obesity in germ-free
mice. Proc. Natl. Acad. Sci. USA 104, 979–984.
Baeck, C.,Wehr, A., Karlmark, K.R., Heymann, F., Vucur,M., Gassler, N., Huss,
S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012). Pharmacological inhi-Cellbition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration
and steatohepatitis in chronic hepatic injury. Gut 61, 416–426.
Bjo¨rkbacka, H., Kunjathoor, V.V., Moore, K.J., Koehn, S., Ordija, C.M., Lee,
M.A., Means, T., Halmen, K., Luster, A.D., Golenbock, D.T., and Freeman,
M.W. (2004). Reduced atherosclerosis in MyD88-null mice links elevated
serum cholesterol levels to activation of innate immunity signaling pathways.
Nat. Med. 10, 416–421.
Buckley, J.D., and Howe, P.R. (2009). Anti-obesity effects of long-chain
omega-3 polyunsaturated fatty acids. Obes. Rev. 10, 648–659.
Caesar, R., Fa˚k, F., and Ba¨ckhed, F. (2010). Effects of gut microbiota on
obesity and atherosclerosis via modulation of inflammation and lipid meta-
bolism. J. Intern. Med. 268, 320–328.
Caesar, R., Reigstad, C.S., Ba¨ckhed, H.K., Reinhardt, C., Ketonen, M.,
Lunde´n, G.O¨., Cani, P.D., and Ba¨ckhed, F. (2012). Gut-derived lipopolysac-
charide augments adipose macrophage accumulation but is not essential for
impaired glucose or insulin tolerance in mice. Gut 61, 1701–1707.
Calder, P.C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflam-
matory diseases. Am. J. Clin. Nutr. 83, 1505S–1519S.
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D.,
Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., et al. (2007). Metabolic en-
dotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S.,
Fortier, M., Greenberg, A.S., and Obin, M.S. (2005). Adipocyte death defines
macrophage localization and function in adipose tissue of obese mice and hu-
mans. J. Lipid Res. 46, 2347–2355.
Creely, S.J., McTernan, P.G., Kusminski, C.M., Fisher, M., Da Silva, N.F.,
Khanolkar, M., Evans, M., Harte, A.L., and Kumar, S. (2007). Lipopolysaccharide
activates an innate immune system response in human adipose tissue in
obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292, E740–E747.
David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E.,
Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al.
(2014). Diet rapidly and reproducibly alters the human gut microbiome.
Nature 505, 559–563.
Devkota, S., Wang, Y., Musch, M.W., Leone, V., Fehlner-Peach, H.,
Nadimpalli, A., Antonopoulos, D.A., Jabri, B., and Chang, E.B. (2012).
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and co-
litis in Il10-/- mice. Nature 487, 104–108.
Ding, S., Chi, M.M., Scull, B.P., Rigby, R., Schwerbrock, N.M.J., Magness, S.,
Jobin, C., and Lund, P.K. (2010). High-fat diet: bacteria interactions promote
intestinal inflammation which precedes and correlates with obesity and insulin
resistance in mouse. PLoS ONE 5, e12191.
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B.,
Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. (2013). Cross-
talk between Akkermansia muciniphila and intestinal epithelium controls
diet-induced obesity. Proc. Natl. Acad. Sci. USA 110, 9066–9071.
Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T.,
Denis, R.G.P., Cochez, P., Pierard, F., Castel, J., et al. (2014). Intestinal epithe-
lial MyD88 is a sensor switching hostmetabolism towards obesity according to
nutritional status. Nat. Commun. 5, 5648.
Fleissner, C.K., Huebel, N., Abd El-Bary, M.M., Loh, G., Klaus, S., andBlaut, M.
(2010). Absence of intestinal microbiota does not protect mice from diet-
induced obesity. Br. J. Nutr. 104, 919–929.
Guarner, F., Perdigon, G., Corthier, G., Salminen, S., Koletzko, B., and Morelli,
L. (2005). Should yoghurt cultures be considered probiotic? Br. J. Nutr. 93,
783–786.
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., Thaiss,
C.A., Kau, A.L., Eisenbarth, S.C., Jurczak, M.J., et al. (2012). Inflammasome-
mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482,
179–185.
Hooper, L.V., Littman, D.R., and Macpherson, A.J. (2012). Interactions be-
tween the microbiota and the immune system. Science 336, 1268–1273.
Hosoi, T., Yokoyama, S., Matsuo, S., Akira, S., and Ozawa, K. (2010). Myeloid
differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice.
PLoS ONE 5, e12537.Metabolism 22, 658–668, October 6, 2015 ª2015 The Authors 667
Huang, S., Rutkowsky, J.M., Snodgrass, R.G., Ono-Moore, K.D., Schneider,
D.A., Newman, J.W., Adams, S.H., and Hwang, D.H. (2012). Saturated fatty
acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid
Res. 53, 2002–2013.
Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D.,
Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal
Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.
Jin, C., and Flavell, R.A. (2013). Innate sensors of pathogen and stress: linking
inflammation to obesity. J. Allergy Clin. Immunol. 132, 287–294.
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N.,
Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al.
(2006). Overexpression of monocyte chemoattractant protein-1 in adipose tis-
sues causes macrophage recruitment and insulin resistance. J. Biol. Chem.
281, 26602–26614.
Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa,
S., Miyachi, H., Maeda, S., Egashira, K., and Kasuga, M. (2006). MCP-1 con-
tributes to macrophage infiltration into adipose tissue, insulin resistance, and
hepatic steatosis in obesity. J. Clin. Invest. 116, 1494–1505.
Kennedy, A., Martinez, K., Chuang, C.-C., LaPoint, K., and McIntosh, M.
(2009). Saturated fatty acid-mediated inflammation and insulin resistance in
adipose tissue: mechanisms of action and implications. J. Nutr. 139, 1–4.
Kim, J.J., and Sears, D.D. (2010). TLR4 and insulin resistance. Gastroenterol.
Res. Pract. 2010, 11.
Kopp, A., Buechler, C., Neumeier, M., Weigert, J., Aslanidis, C., Scho¨lmerich,
J., and Scha¨ffler, A. (2009). Innate immunity and adipocyte function: ligand-
specific activation of multiple Toll-like receptors modulates cytokine, adipo-
kine, and chemokine secretion in adipocytes. Obesity (Silver Spring) 17,
648–656.
Kriegel, M.A., Sefik, E., Hill, J.A., Wu, H.-J., Benoist, C., and Mathis, D. (2011).
Naturally transmitted segmented filamentous bacteria segregatewith diabetes
protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108, 11548–
11553.
Kulkarni, O., Pawar, R.D., Purschke, W., Eulberg, D., Selve, N., Buchner, K.,
Ninichuk, V., Segerer, S., Vielhauer, V., Klussmann, S., and Anders, H.J.
(2007). Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in
MRL-(Fas)lpr mice. J. Am. Soc. Nephrol. 18, 2350–2358.
Kulkarni, O., Eulberg, D., Selve, N., Zo¨llner, S., Allam, R., Pawar, R.D., Pfeiffer,
S., Segerer, S., Klussmann, S., and Anders, H.J. (2009). Anti-Ccl2 Spiegelmer
permits 75% dose reduction of cyclophosphamide to control diffuse prolifer-
ative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J. Pharmacol.
Exp. Ther. 328, 371–377.
Larsson, E., Tremaroli, V., Lee, Y.S., Koren, O., Nookaew, I., Fricker, A.,
Nielsen, J., Ley, R.E., and Ba¨ckhed, F. (2012). Analysis of gut microbial regu-
lation of host gene expression along the length of the gut and regulation of gut
microbial ecology through MyD88. Gut 61, 1124–1131.
Lee, B.-C., and Lee, J. (2014). Cellular and molecular players in adipose tissue
inflammation in the development of obesity-induced insulin resistance.
Biochim. Biophys. Acta 1842, 446–462.668 Cell Metabolism 22, 658–668, October 6, 2015 ª2015 The AuthoMichelsen, K.S., Wong, M.H., Shah, P.K., Zhang, W., Yano, J., Doherty, T.M.,
Akira, S., Rajavashisth, T.B., and Arditi, M. (2004). Lack of Toll-like receptor 4
or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque
phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA
101, 10679–10684.
Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu,
W.J., Watkins, S.M., and Olefsky, J.M. (2010). GPR120 is an omega-3 fatty
acid receptor mediating potent anti-inflammatory and insulin-sensitizing ef-
fects. Cell 142, 687–698.
Rabot, S., Membrez, M., Bruneau, A., Ge´rard, P., Harach, T., Moser, M.,
Raymond, F., Mansourian, R., and Chou, C.J. (2010). Germ-free C57BL/6J
mice are resistant to high-fat-diet-induced insulin resistance and have altered
cholesterol metabolism. FASEB J. 24, 4948–4959.
Richards, M.R., Black, A.S., Bonnet, D.J., Barish, G.D., Woo, C.W., Tabas, I.,
Curtiss, L.K., and Tobias, P.S. (2013). The LPS2 mutation in TRIF is atheropro-
tective in hyperlipidemic low density lipoprotein receptor knockout mice.
Innate Immun. 19, 20–29.
Scott, K.P., Gratz, S.W., Sheridan, P.O., Flint, H.J., and Duncan, S.H. (2013).
The influence of diet on the gut microbiota. Pharmacol. Res. 69, 52–60.
Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. (2006).
TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin.
Invest. 116, 3015–3025.
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T.W., Lee, M.-S., and
Bae, J.-W. (2014). An increase in the Akkermansia spp. population induced
by metformin treatment improves glucose homeostasis in diet-induced obese
mice. Gut 63, 727–735.
Tremaroli, V., and Ba¨ckhed, F. (2012). Functional interactions between the gut
microbiota and host metabolism. Nature 489, 242–249.
Velagapudi, V.R., Hezaveh, R., Reigstad, C.S., Gopalacharyulu, P., Yetukuri,
L., Islam, S., Felin, J., Perkins, R., Bore´n, J., Oresic, M., and Ba¨ckhed, F.
(2010). The gut microbiota modulates host energy and lipid metabolism in
mice. J. Lipid Res. 51, 1101–1112.
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and
Ferrante, A.W., Jr. (2003). Obesity is associated with macrophage accumula-
tion in adipose tissue. J. Clin. Invest. 112, 1796–1808.
Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K.,
Charo, I., Leibel, R.L., and Ferrante, A.W., Jr. (2006). CCR2 modulates in-
flammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116,
115–124.
Wlotzka, B., Leva, S., Eschgfa¨ller, B., Burmeister, J., Kleinjung, F., Kaduk, C.,
Muhn, P., Hess-Stumpp, H., and Klussmann, S. (2002). In vivo properties of an
anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic
substance class. Proc. Natl. Acad. Sci. USA 99, 8898–8902.
Yu, L., Wang, L., and Chen, S. (2010). Endogenous toll-like receptor ligands
and their biological significance. J. Cell. Mol. Med. 14, 2592–2603.rs
